RxDoctor Payments Data

Babak Samimi, MD

Orthopaedic Surgery · Los Angeles, CANPI 1912121377

Payments from drug & device makers

$191,101in general payments, 2019–2025

Across 275 payments — averaging $694.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$145K
  • Smith+Nephew$43K
  • Fuse Medical, Inc.$500
  • CPM Medical Consultants, LLC$426
  • Linvatec Corporation$334
  • Ortho Systems$270
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$15,6948%
  • Speaking & faculty fees$155,12181%
  • Travel & lodging$13,9427%
  • Food & beverage$6,0753%
  • Education$2700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex162$145,154
Smith+Nephew61$43,144
Fuse Medical, Inc.1$500
CPM Medical Consultants, LLC3$426
Linvatec Corporation9$334
Ortho Systems1$270
Stryker4$247
Zimmer Biomet7$204
Amgen8$149
Shoulder Innovations, Inc.2$123
Vertex3$99
Abbott1$88
Sportstek Medical, Inc1$79
Globus Medical3$78
Bioventus LLC2$60
Vericel Corporation2$48
Electronic Waveform Lab, Inc.1$31
Medtronic2$29
Pacira Pharmaceuticals Incorporated1$21
ERMI LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$191,101 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$201,519
Medicare patients
309
Services billed
8,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium12$289
Meloxicam58$126
Methylprednisolone15$88
Gabapentin11$62

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →